Coronary Microcirculation and the No-reflow Phenomenon

Area of Science:

• Cardiology
• Cardiovascular Research
• Interventional Cardiology

Background:

• The no-reflow phenomenon is a critical complication following percutaneous coronary intervention (PCI).
• It significantly impairs myocardial perfusion despite restored epicardial artery patency.
• This condition limits the efficacy of reperfusion therapy and leads to adverse clinical outcomes.

Purpose of the Study:

• To provide an updated overview of the pathophysiological mechanisms underlying the no-reflow phenomenon.
• To review current preventive strategies for no-reflow.
• To discuss therapeutic interventions aimed at improving coronary blood flow and patient prognosis.

Main Methods:

• Literature review of pathophysiological mechanisms.
• Analysis of current preventive tools and therapeutic interventions.
• Synthesis of updated information on no-reflow management.

Main Results:

• No-reflow involves complex microvascular alterations, including inflammation, vascular damage, hemorrhage, leukocyte infiltration, and cellular edema.
• Several preventive strategies exist, though their efficacy varies.
• Therapeutic interventions focus on mitigating microvascular dysfunction to improve perfusion.

Conclusions:

• The pathophysiology of no-reflow is multifactorial, involving microvascular dysfunction.
• Effective prevention and timely therapeutic interventions are crucial for improving outcomes in patients experiencing no-reflow.
• Further research into precise mechanisms can optimize treatment strategies.